Dipeptidyl Peptidase

Dipeptidyl Peptidase Related Products (55):

By Effects:	Inhibitors (50) Activator (1)

Cat. No.	Product Name	Effect	Purity

HY-10284

Linagliptin	Inhibitor	99.91%
Linagliptin is a highly potent, selective DPP-4 inhibitor with IC₅₀ of 1 nM.

HY-14291

Vildagliptin	Inhibitor	99.61%
Vildagliptin (LAF237) is a potent, stable, selective dipeptidyl peptidase IV (DPP-IV) inhibitor with an IC₅₀ of 3.5 nM in human Caco-2 cells. Vildagliptin possesses excellent oral bioavailability and potent antihyperglycemic activity.

HY-15981

Omarigliptin	Inhibitor
Omarigliptin (MK-3102) is a potent, selective, orally active and cross the blood-brain barrier dipeptidyl peptidase 4 (DPP-4) inhibitor. Omarigliptin shows anti-parkinsonian activity. Omarigliptin has the neuroprotective effect to improve diabetes-associated cognitive dysfunction.

HY-13749B

Sitagliptin phosphate monohydrate	Inhibitor	99.49%
Sitagliptin phosphate monohydrate (MK-0431 phosphate monohydrate) is a potent inhibitor of DPP4 with an IC₅₀ of 19 nM in Caco-2 cell extracts.

HY-111174

Diprotin A	Inhibitor	99.58%
Diprotin A (Ile-Pro-Ile) is an inhibitor of dipeptidyl peptidase IV (DPP-IV).

HY-160073A

DPP1-IN-1 hydrate	Inhibitor
DPP1-IN-1 hydrate is a DPP1 inhibitor (IC₅₀: 1.6 nM). DPP1-IN-1 hydrate has good bioavailability and pharmacokinetic characteristics, and can be used for research of inflammatory disease.

HY-157390

DPP-4-IN-9	Inhibitor
DPP-4-IN-9 (compound 6l) is a potent inhibitor of dipeptidyl peptidase DPP-4 (IC₅₀: 8.22 nM). DPP-4-IN-9 has antihyperglycemic activity.

HY-160073

DPP1-IN-1	Inhibitor
DPP1-IN-1 (compound 1) is a potent inhibitor of DPP1. DPP1-IN-1 can used in study bronchiectasis.

HY-14806

Teneligliptin	Inhibitor	99.85%
Teneligliptin (MP-513) is a potent, orally available, competitive, and long-lasting DPP-4 inhibitor. Teneligliptin competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC₅₀s of approximately 1 nM.

HY-A0023

Alogliptin Benzoate	Inhibitor	99.99%
Alogliptin Benzoate (SYR-322) is a potent, selective and orally active inhibitor of DPP-4 with an IC₅₀ of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin Benzoate can be used for the research of type 2 diabetes.

HY-A0023A

Alogliptin	Inhibitor	99.92%
Alogliptin (SYR-322 free base) is a potent, selective and orally active inhibitor of DPP-4 with an IC₅₀ of <10 nM, and exhibits greater than 10,000-fold selectivity over DPP-8 and DPP-9. Alogliptin can be used for the research of type 2 diabetes.

HY-B0422

Nateglinide	Inhibitor	99.51%
Nateglinide, a D-phenylalanine derivative, is an orally active and short-acting insulinotropic agent and a DPP IV inhibitor. Nateglinide inhibits ATP-sensitive K⁺ channels in pancreatic β-cells. Nateglinide is used for the treatment of type 2 (non-insulin-dependent) diabetes mellitus.

HY-111174A

Diprotin A TFA	Inhibitor	99.55%
Diprotin A TFA (Ile-Pro-Ile TFA) is an inhibitor of dipeptidyl peptidase IV (DPP-IV).

HY-14892A

Gemigliptin tartrate	Inhibitor	98.17%
Gemigliptin tartrate (LC15-0444 tartrate) is a highly selective, reversible and competitive dipeptidyl peptidase-4 (DPP-4) inhibitor, with an IC₅₀ of 10.3 nM for human recombinant DPP-4. Gemigliptin tartrate exhibits potent anti-glycation properties. Gemigliptin tartrate can be used for the research of advanced glycation end products (AGE)-related diabetic complications.

HY-14806A

Teneligliptin hydrobromide	Inhibitor	99.99%
Teneligliptin (MP-513) hydrobromide is a potent chemotype prolylthiazolidine-based DPP-4 inhibitor, which competitively inhibits human plasma, rat plasma, and human recombinant DPP-4 in vitro, with IC₅₀s of approximately 1 nM.

HY-15408A

Trelagliptin succinate	Inhibitor	99.96%
Trelagliptin (SYR-472) succinate is a potent, orally active and highly selective DPP-4 inhibitor with an IC₅₀ of 4 nM. Trelagliptin succinate improves glycemic control in vivo and can be used for the study of type 2 diabetes mellitus (T2DM).

HY-112668

Retagliptin phosphate	Inhibitor	99.89%
Retagliptin phosphate (SP2086 phosphate) is a selective, competitive and orally active dipeptidyl peptidase-4 (DPP-4) inhibitor. Retagliptin phosphate can be used for type 2 diabetes mellitus (T2DM) research.

HY-108319

DPP-IV-IN-2	Inhibitor	≥98.0%
DPP-IV-IN-2 is an inhibitor of both dipeptidyl peptidase IV (DPIV) and DP8/9 with IC₅₀s of 0.1 and 0.95 μM, respectively.

HY-101769

UAMC00039 dihydrochloride	Inhibitor	99.81%
UAMC00039 dihydrochloride is a potent, reversible and competitive dipeptidyl peptidase II inhibitor with an IC₅₀ of 0.48 nM.

HY-13233B

Talabostat isomer mesylate		≥98.0%
Talabostat isomer mesylate is an isomer of talabostat mesylate. Talabostat (PT100, Val-boroPro) is a potent, nonselective and orally available dipeptidyl peptidase IV (DPP-IV) inhibitor with a K_i of 0.18 nM.

Name
Email *

	Sorry, but the email address you supplied was invalid.